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Letters to the
Editor
Candidate gene association analysis
of thoracic aortic aneurysm
and dissection
To the Editor:
In their recent article, Chen and col-
leagues1 have described the association of
three single-nucleotide polymorphisms of
the matrix metalloproteinase 9 gene, with
thoracic aortic aneurysm and dissection.
One of the three single-nucleotide poly-
morphisms (A-8202G) was found to be as-
sociated with the disease phenotypes of
aortic aneurysm and aortic dissection. Such
genetic association studies are based on the
presence of linkage disequilibrium in the hu-
man genome and can be a powerful tool to
dissect the genetic basis of diseases. A fun-
damental aspect of this approach, however, is
the meticulous selection and matching of un-
related study subjects (case and control sub-
jects). We believe that this study has some
basic weaknesses; hence the results should
be viewed with caution.
First, Chen and colleagues1 compared
the prevalence of alleles and genotypes at
the three loci between patients recruited
from the United States and their control
subjects from Australia. In our opinion, the
case and control subjects belong to two
very distinct populations, and their com-
parison cannot yield any meaningful evi-
dence. It is a common observation in
genetic association studies that genetic
markers have diverse, and in some cases
even opposite, associations in different eth-
nic groups.2-4 The strength of linkage dis-
equilibrium between any two loci will not
be equal in any two different ethnic groups,
hence the importance of ethnicity-matched
control subjects.
Second, Chen and colleagues1 should
comment on the presence of Hardy-
Weinberg equilibrium in the genotype dis-
tributions at the three loci separately for the
case and control groups. Hardy-Weinberg
equilibrium in the genotype distributions
provides evidence of random selection of
subjects, which is an important pillar of the
case-control genetic association study de-
sign. Furthermore, if the genotypes at the
three loci are in Hardy-Weinberg equilib-
rium in case and control subjects, then it
will be interesting to see the prevalence of
the various haplotypes in the study popu-
lation and also their associations with the
diagnoses under study. This may provide
additional information about the role of
matrix metalloproteinase polymorphisms
in thoracic aortic aneurysm and dissection.
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Reply to the Editor:
We appreciate the comments by Ahmad
and colleagues regarding our initial inves-
tigation of single nucleotide polymor-
phisms (SNPs) involving the matrix metal-
loproteinase 9 gene (MMP9) in patients
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with thoracic aortic pathology.1 Selection
of a control group that is perfectly matched
for ethnic ancestry with a group of affected
individuals is indeed a major challenge in
studying the associations between candi-
date genes and diseases. Not surprisingly,
most published studies have imperfectly
matched case-control populations. Never-
theless, the substantial geographic differ-
ence between our control and study popu-
lations clearly warrants discussion.
Although geographically diverse, white
populations from Australia and the United
States are genetically similar. The majority of
the white Australian population has ancestors
who, within only a few generations, origi-
nated from the European continent. Previous
studies of other genetic polymorphisms have
demonstrated great similarities between the
white Australian population and white sub-
jects residing on other continents.2,3 Our
American patients with thoracic aortic dis-
ease were classified as white with European
origin and therefore share a similar genetic
origin with white Australians. Although the
Australian and American populations have
resided on two different continents for a
number of generations, the migration and
constitutive establishment for both countries
date back only approximately 200 years. The
founder effect is generally small within such
a short period. Still, even within a given
white population, genetic admixture can be
large for certain genes. Because of this and
other inherent limitations, studies in separate
populations are required to confirm any sig-
nificant genetic associations observed from
one particular population.
Given the genetic similarities between
white Australians and white Americans (de-
spite the geographic difference), we chose
our control population for the absence of
angiographic evidence of proximal thoracic
aortic aneurysms or dissection. This reduced
the likelihood that control subjects had tho-
racic aortic disease, which would have con-
founded the comparisons with our patient
groups. To address at least somewhat the
issue of geographic diversity in our study,
we demonstrated that the frequencies of the
three MMP9 SNPs in our control group
were not significantly different from those
previously described by Applied Biosys-
tems (Foster City, Calif) in a white popu-
lation from the United States.1 The pres-
ence of Hardy-Weinberg equilibrium in the
control group is also reassuring; there
was no significant deviation from Hardy-
Weinberg equilibrium for the three MMP9
polymorphisms in the control group (P 
.81 for -8202A/G; P  .98 for IVS4 
3G/T; P  .93 for 2003A/G). No signifi-
cant deviation from Hardy-Weinberg equi-
librium was observed for IVS43G/T and
2003A/G in patients with thoracic aortic
aneurysms or dissection; a significant de-
viation from Hardy-Weinberg equilibrium
was observed for -8202A/G in our case
patients.
Recent publications have suggested the
existence of haplotype blocks. Haplotypes at
these blocks could serve as multiallelic mark-
ers in disease-association studies.4 Examin-
ing all observed haplotypes for associations,
rather than just those that are proxies for
known SNPs, increases power to detect rare
causal alleles, but at the cost of reduced
power to detect common causal alleles.
Furthermore, the haplotype-SNP– based
approach does not always have higher
power than the single-SNP–based study, as
is supported by theoretic considerations.
With the data collected in our population,
some linkage analysis can be conducted for
haplotype construction. Estimated haplo-
type frequencies cannot be treated as ob-
served data, however, and therefore there is
no valid statistical test for evaluating the
possible contribution of individual haplo-
types. Although testing haplotype blocks of
the MMP9 locus and surrounding regions
by including more SNPs might provide ad-
ditional information, the most effective
way to validate the findings reported in our
study is to confirm the association in other
case-control populations.
As with all genetic association stud-
ies, our study has limitations and the
findings should be interpreted cautiously.
Studies in separate populations will be
required to confirm the association that
we observed between the MMP9
-8202A/G polymorphism and thoracic
aortic aneurysms and dissection. We hope
that our data will stimulate expanded re-
search regarding the genetic aspects of tho-
racic aortic disease, particularly in patients
who do not have archetypal heritable disor-
ders such as Marfan syndrome. Our partici-
pation in the newly established Specialized
Center of Clinically Oriented Research in
Thoracic Aortic Aneurysms and Dissection
will provide exciting opportunities to per-
form such studies and expand our under-
standing of the genetic determinants that
underlie thoracic aortic disease.
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Placement of the Impella Recover LD
microaxial blood pump through a
bioprosthesis is technically feasible
To the Editor:
We read with great interest the article of
Strauch and colleagues1 regarding their ex-
perience with Impella Recover LD support
for postcardiotomy low-output syndrome in a
patient undergoing aortic valve replacement
with a bioprosthesis. In our initial experi-
ence2 we reported the use of the Impella
Recover LD to support a patient with valvu-
lar cardiomyopathy who underwent conven-
tional mitral valve repair and aortic valve
replacement with a 21 mm Carpentier-Ed-
wards bioprosthesis. Despite maximal ino-
tropic support (epinephrine dose, 0.2 g/
kg1/min1), the patient could not be
weaned from extracorporeal circulation,
with hypotension, increased filling pressure
(left atrial pressure, 28 mm Hg), and oli-
guria (urine output, 30 mL/h). The cal-
culated intra-aortic balloon pump (IABP)
score for the patient was 2, which predicts
a 52% 30-day mortality according to Haus-
mann and coworkers.3 The Impella LD
was then implanted with the standard tech-
nique and advanced in the left ventricle
through the prosthesis under echocardio-
graphic guidance. In our experience pass-
ing the biologic valve was not immediate
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